Bio-pharma Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, China, Japan - Size and Forecast 2024-2028

1 Executive Summary

• 1.1 Market overview
  • Figure 01: Executive Summary – Chart on Market Overview
  • Figure 02: Executive Summary – Data Table on Market Overview
  • Figure 03: Executive Summary – Chart on Global Market Characteristics
  • Figure 04: Executive Summary – Chart on Market by Geography
  • Figure 05: Executive Summary – Chart on Market Segmentation by Product
  • Figure 06: Executive Summary – Chart on Market Segmentation by Application
  • Figure 07: Executive Summary – Chart on Incremental Growth
  • Figure 08: Executive Summary – Data Table on Incremental Growth
  • Figure 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Figure 10: Parent market
  • Figure 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
  • Figure 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
  • Figure 13: Market segments

• 3.3 Market size 2023

• 3.4 Market outlook: Forecast for 2023-2028
  • Figure 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Figure 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Figure 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Figure 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global biopharmaceutical market 2018 - 2022
  • Figure 18: Historic Market Size – Data Table on global biopharmaceutical market 2018 - 2022 ($ billion)

• 4.2 Product Segment Analysis 2018 - 2022
  • Figure 19: Historic Market Size – Product Segment 2018 - 2022 ($ billion)

• 4.3 Application Segment Analysis 2018 - 2022
  • Figure 20: Historic Market Size – Application Segment 2018 - 2022 ($ billion)

• 4.4 Geography Segment Analysis 2018 - 2022
  • Figure 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

• 4.5 Country Segment Analysis 2018 - 2022
  • Figure 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Figure 23: Five forces analysis - Comparison between 2023 and 2028

• 5.2 Bargaining power of buyers
  • Figure 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

• 5.3 Bargaining power of suppliers
  • Figure 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

• 5.4 Threat of new entrants
  • Figure 26: Threat of new entrants – Impact of key factors in 2023 and 2028

• 5.5 Threat of substitutes
  • Figure 27: Threat of substitutes – Impact of key factors in 2023 and 2028

• 5.6 Threat of rivalry
  • Figure 28: Threat of rivalry – Impact of key factors in 2023 and 2028

• 5.7 Market condition
  • Figure 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
  • Figure 30: Chart on Product - Market share 2023-2028 (%)
  • Figure 31: Data Table on Product - Market share 2023-2028 (%)

• 6.2 Comparison by Product
  • Figure 32: Chart on Comparison by Product
  • Figure 33: Data Table on Comparison by Product

• 6.3 Monoclonal antibodies - Market size and forecast 2023-2028
  • Figure 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
  • Figure 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
  • Figure 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
  • Figure 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)

• 6.4 Recombinant growth factors - Market size and forecast 2023-2028
  • Figure 38: Chart on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
  • Figure 39: Data Table on Recombinant growth factors - Market size and forecast 2023-2028 ($ billion)
  • Figure 40: Chart on Recombinant growth factors - Year-over-year growth 2023-2028 (%)
  • Figure 41: Data Table on Recombinant growth factors - Year-over-year growth 2023-2028 (%)

• 6.5 Vaccines - Market size and forecast 2023-2028
  • Figure 42: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
  • Figure 43: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
  • Figure 44: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
  • Figure 45: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)

• 6.6 Recombinant hormones - Market size and forecast 2023-2028
  • Figure 46: Chart on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
  • Figure 47: Data Table on Recombinant hormones - Market size and forecast 2023-2028 ($ billion)
  • Figure 48: Chart on Recombinant hormones - Year-over-year growth 2023-2028 (%)
  • Figure 49: Data Table on Recombinant hormones - Year-over-year growth 2023-2028 (%)

• 6.7 Others - Market size and forecast 2023-2028
  • Figure 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Figure 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Figure 52: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Figure 53: Data Table on Others - Year-over-year growth 2023-2028 (%)

• 6.8 Market opportunity by Product
  • Figure 54: Market opportunity by Product ($ billion)
  • Figure 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Application

• 7.1 Market segments
  • Figure 56: Chart on Application - Market share 2023-2028 (%)
  • Figure 57: Data Table on Application - Market share 2023-2028 (%)

• 7.2 Comparison by Application
  • Figure 58: Chart on Comparison by Application
  • Figure 59: Data Table on Comparison by Application

• 7.3 Oncology - Market size and forecast 2023-2028
  • Figure 60: Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
  • Figure 61: Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
  • Figure 62: Chart on Oncology - Year-over-year growth 2023-2028 (%)
  • Figure 63: Data Table on Oncology - Year-over-year growth 2023-2028 (%)

• 7.4 Autoimmune disorder - Market size and forecast 2023-2028
  • Figure 64: Chart on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
  • Figure 65: Data Table on Autoimmune disorder - Market size and forecast 2023-2028 ($ billion)
  • Figure 66: Chart on Autoimmune disorder - Year-over-year growth 2023-2028 (%)
  • Figure 67: Data Table on Autoimmune disorder - Year-over-year growth 2023-2028 (%)

• 7.5 Metabolic disorder - Market size and forecast 2023-2028
  • Figure 68: Chart on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
  • Figure 69: Data Table on Metabolic disorder - Market size and forecast 2023-2028 ($ billion)
  • Figure 70: Chart on Metabolic disorder - Year-over-year growth 2023-2028 (%)
  • Figure 71: Data Table on Metabolic disorder - Year-over-year growth 2023-2028 (%)

• 7.6 Hormonal disorder - Market size and forecast 2023-2028
  • Figure 72: Chart on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
  • Figure 73: Data Table on Hormonal disorder - Market size and forecast 2023-2028 ($ billion)
  • Figure 74: Chart on Hormonal disorder - Year-over-year growth 2023-2028 (%)
  • Figure 75: Data Table on Hormonal disorder - Year-over-year growth 2023-2028 (%)

• 7.7 Others - Market size and forecast 2023-2028
  • Figure 76: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Figure 77: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Figure 78: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Figure 79: Data Table on Others - Year-over-year growth 2023-2028 (%)

• 7.8 Market opportunity by Application
  • Figure 80: Market opportunity by Application ($ billion)
  • Figure 81: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Figure 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Figure 83: Chart on Market share by geography 2023-2028 (%)
  • Figure 84: Data Table on Market share by geography 2023-2028 (%)

• 9.2 Geographic comparison
  • Figure 85: Chart on Geographic comparison
  • Figure 86: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2023-2028
  • Figure 87: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Figure 88: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Figure 89: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Figure 90: Data Table on North America - Year-over-year growth 2023-2028 (%)

• 9.4 Europe - Market size and forecast 2023-2028
  • Figure 91: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Figure 92: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Figure 93: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Figure 94: Data Table on Europe - Year-over-year growth 2023-2028 (%)

• 9.5 Asia - Market size and forecast 2023-2028
  • Figure 95: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Figure 96: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Figure 97: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Figure 98: Data Table on Asia - Year-over-year growth 2023-2028 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Figure 99: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Figure 100: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Figure 101: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Figure 102: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

• 9.7 US - Market size and forecast 2023-2028
  • Figure 103: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Figure 104: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Figure 105: Chart on US - Year-over-year growth 2023-2028 (%)
  • Figure 106: Data Table on US - Year-over-year growth 2023-2028 (%)

• 9.8 China - Market size and forecast 2023-2028
  • Figure 107: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Figure 108: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Figure 109: Chart on China - Year-over-year growth 2023-2028 (%)
  • Figure 110: Data Table on China - Year-over-year growth 2023-2028 (%)

• 9.9 Germany - Market size and forecast 2023-2028
  • Figure 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Figure 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Figure 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Figure 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)

• 9.10 France - Market size and forecast 2023-2028
  • Figure 115: Chart on France - Market size and forecast 2023-2028 ($ billion)
  • Figure 116: Data Table on France - Market size and forecast 2023-2028 ($ billion)
  • Figure 117: Chart on France - Year-over-year growth 2023-2028 (%)
  • Figure 118: Data Table on France - Year-over-year growth 2023-2028 (%)

• 9.11 Japan - Market size and forecast 2023-2028
  • Figure 119: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
  • Figure 120: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
  • Figure 121: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Figure 122: Data Table on Japan - Year-over-year growth 2023-2028 (%)

• 9.12 Market opportunity by geography
  • Figure 123: Market opportunity by geography ($ billion)
  • Figure 124: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges
  • Figure 125: Impact of drivers and challenges in 2023 and 2028

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
  • Figure 126: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
  • Figure 127: Overview on factors of disruption

• 11.4 Industry risks
  • Figure 128: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
  • Figure 129: Vendors covered

• 12.2 Market positioning of vendors
  • Figure 130: Matrix on vendor position and classification

• 12.3 AbbVie Inc.
  • Figure 131: AbbVie Inc. - Overview
  • Figure 132: AbbVie Inc. - Product / Service
  • Figure 133: AbbVie Inc. - Key news
  • Figure 134: AbbVie Inc. - Key offerings

• 12.4 Amgen Inc.
  • Figure 135: Amgen Inc. - Overview
  • Figure 136: Amgen Inc. - Product / Service
  • Figure 137: Amgen Inc. - Key offerings

• 12.5 Astellas Pharma Inc.
  • Figure 138: Astellas Pharma Inc. - Overview
  • Figure 139: Astellas Pharma Inc. - Product / Service
  • Figure 140: Astellas Pharma Inc. - Key news
  • Figure 141: Astellas Pharma Inc. - Key offerings

• 12.6 AstraZeneca Plc
  • Figure 142: AstraZeneca Plc - Overview
  • Figure 143: AstraZeneca Plc - Product / Service
  • Figure 144: AstraZeneca Plc - Key news
  • Figure 145: AstraZeneca Plc - Key offerings

• 12.7 Bayer AG
  • Figure 146: Bayer AG - Overview
  • Figure 147: Bayer AG - Business segments
  • Figure 148: Bayer AG - Key news
  • Figure 149: Bayer AG - Key offerings
  • Figure 150: Bayer AG - Segment focus

• 12.8 Biogen Inc.
  • Figure 151: Biogen Inc. - Overview
  • Figure 152: Biogen Inc. - Product / Service
  • Figure 153: Biogen Inc. - Key offerings

• 12.9 Bristol Myers Squibb Co.
  • Figure 154: Bristol Myers Squibb Co. - Overview
  • Figure 155: Bristol Myers Squibb Co. - Product / Service
  • Figure 156: Bristol Myers Squibb Co. - Key news
  • Figure 157: Bristol Myers Squibb Co. - Key offerings

• 12.10 Eli Lilly and Co.
  • Figure 158: Eli Lilly and Co. - Overview
  • Figure 159: Eli Lilly and Co. - Product / Service
  • Figure 160: Eli Lilly and Co. - Key news
  • Figure 161: Eli Lilly and Co. - Key offerings

• 12.11 F. Hoffmann La Roche Ltd.
  • Figure 162: F. Hoffmann La Roche Ltd. - Overview
  • Figure 163: F. Hoffmann La Roche Ltd. - Business segments
  • Figure 164: F. Hoffmann La Roche Ltd. - Key news
  • Figure 165: F. Hoffmann La Roche Ltd. - Key offerings
  • Figure 166: F. Hoffmann La Roche Ltd. - Segment focus

• 12.12 Johnson and Johnson
  • Figure 167: Johnson and Johnson - Overview
  • Figure 168: Johnson and Johnson - Business segments
  • Figure 169: Johnson and Johnson - Key news
  • Figure 170: Johnson and Johnson - Key offerings
  • Figure 171: Johnson and Johnson - Segment focus

• 12.13 Novartis AG
  • Figure 172: Novartis AG - Overview
  • Figure 173: Novartis AG - Business segments
  • Figure 174: Novartis AG - Key offerings
  • Figure 175: Novartis AG - Segment focus

• 12.14 Novo Nordisk AS
  • Figure 176: Novo Nordisk AS - Overview
  • Figure 177: Novo Nordisk AS - Business segments
  • Figure 178: Novo Nordisk AS - Key offerings
  • Figure 179: Novo Nordisk AS - Segment focus

• 12.15 Pfizer Inc.
  • Figure 180: Pfizer Inc. - Overview
  • Figure 181: Pfizer Inc. - Product / Service
  • Figure 182: Pfizer Inc. - Key news
  • Figure 183: Pfizer Inc. - Key offerings

• 12.16 Sanofi SA
  • Figure 184: Sanofi SA - Overview
  • Figure 185: Sanofi SA - Business segments
  • Figure 186: Sanofi SA - Key news
  • Figure 187: Sanofi SA - Key offerings
  • Figure 188: Sanofi SA - Segment focus

• 12.17 Takeda Pharmaceutical Co. Ltd.
  • Figure 189: Takeda Pharmaceutical Co. Ltd. - Overview
  • Figure 190: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Figure 191: Takeda Pharmaceutical Co. Ltd. - Key news
  • Figure 192: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist
  • Figure 193: Inclusions checklist
  • Figure 194: Exclusions checklist

• 13.3 Currency conversion rates for US$
  • Figure 195: Currency conversion rates for US$

• 13.4 Research methodology
  • Figure 196: Research methodology
  • Figure 197: Validation techniques employed for market sizing
  • Figure 198: Information sources

• 13.5 List of abbreviations
  • Figure 199: List of abbreviations